Tag:
Rotarix
Latest Headlines
Latest Headlines
GSK's vaccine unit sees revenue, profit jump in Q3
After struggling out of the gate with Novartis' vaccines in hand, GlaxoSmithKline's vaccines unit turned its fortune in the third quarter and was able to deliver considerable increases in sales and profits.
Merck's RotaTeq, Glaxo's Rotarix cut hospitalizations by up to 94%
Rotavirus vaccines RotaTeq and Rotarix from Merck and GlaxoSmithKline, respectively, have seen uptake grow over the past several years. And with good reason, a new study shows: As the vaccines have become more widespread, the number of children hospitalized for rotavirus-related diarrhea has plunged.
CDC, FDA studies link Merck and GSK rotavirus vaccines to bowel blockages
Merck's rotavirus vaccine RotaTeq has faced close scrutiny since winning FDA approval in 2006, with authorities monitoring whether it shares side effects with a similar Wyeth product that was pulled from the market. Now a FDA-funded study has shown RotaTeq is linked to the side effect, but the benefits outweigh the risks.
GSK, Merck vaccines keep kids out of hospital
The number of rotavirus-related hospitalizations in kids under 5 fell by 80% after the shots went into routine use, and the hospitalizations in kids 5-14 years dropped by 70%.
Herd immunity from GSK, Merck vaccines cutting hospitalizations
A U.S. Centers for Disease Control and Prevention team has found a significant decrease in the number of rotavirus-related hospitalizations with routine use of GlaxoSmithKline ($GSK) and Merck's ($MRK) rotavirus vaccines in older age groups.
GSK's rotavirus vaccine as effective as Merck shot
The data dampen concerns about Rotarix' efficacy raised in an earlier clinical trial, and shows both vaccines to be effective.
U.K. vaccine expansion a boon for GSK and Merck
Sales of GlaxoSmithKline's rotavirus vaccine Rotarix and Merck's shingles vaccine Zostavax will be buoyed by their inclusion on the U.K. national immunization schedule.
GSK's rotavirus vaccine selected for British program
British health officials selected GlaxoSmithKline's Rotarix vaccine for the country's first routine rotavirus immunization program.
20 Top-selling Vaccines-- H1 2012
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.
The 20 top-selling vaccines in H1 2012
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>
